Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.

Lajunen T, Hisazumi K, Kanazawa T, Okada H, Seta Y, Yliperttula M, Urtti A, Takashima Y.

Eur J Pharm Sci. 2014 Oct 1;62:23-32. doi: 10.1016/j.ejps.2014.04.018. Epub 2014 May 5.

PMID:
24810393
2.

Light induced cytosolic drug delivery from liposomes with gold nanoparticles.

Lajunen T, Viitala L, Kontturi LS, Laaksonen T, Liang H, Vuorimaa-Laukkanen E, Viitala T, Le Guével X, Yliperttula M, Murtomäki L, Urtti A.

J Control Release. 2015 Apr 10;203:85-98. doi: 10.1016/j.jconrel.2015.02.028. Epub 2015 Feb 19.

PMID:
25701610
3.

Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

Hadinoto K, Sundaresan A, Cheow WS.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Review.

PMID:
23872180
4.

Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs.

El Kechai N, Bochot A, Huang N, Nguyen Y, Ferrary E, Agnely F.

Int J Pharm. 2015 Jun 20;487(1-2):187-96. doi: 10.1016/j.ijpharm.2015.04.019. Epub 2015 Apr 13.

PMID:
25882015
5.

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.

Zalba S, Contreras AM, Haeri A, Ten Hagen TL, Navarro I, Koning G, Garrido MJ.

J Control Release. 2015 Jul 28;210:26-38. doi: 10.1016/j.jconrel.2015.05.271. Epub 2015 May 19.

PMID:
25998052
6.

Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposome.

Fragogeorgi EA, Savina IN, Tsotakos T, Efthimiadou E, Xanthopoulos S, Palamaris L, Psimadas D, Bouziotis P, Kordas G, Mikhalovsky S, Alavijeh M, Loudos G.

Int J Pharm. 2014 Apr 25;465(1-2):333-46. doi: 10.1016/j.ijpharm.2014.01.042. Epub 2014 Feb 26.

PMID:
24583207
7.

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.

Chen CW, Lu DW, Yeh MK, Shiau CY, Chiang CH.

Int J Nanomedicine. 2011;6:2567-80. doi: 10.2147/IJN.S24447. Epub 2011 Oct 26.

8.

Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.

Rezaee M, Oskuee RK, Nassirli H, Malaekeh-Nikouei B.

J Control Release. 2016 Aug 28;236:1-14. doi: 10.1016/j.jconrel.2016.06.023. Epub 2016 Jun 15. Review.

PMID:
27317365
9.

Mixtures of hyaluronic acid and liposomes for drug delivery: Phase behavior, microstructure and mobility of liposomes.

El Kechai N, Geiger S, Fallacara A, Cañero Infante I, Nicolas V, Ferrary E, Huang N, Bochot A, Agnely F.

Int J Pharm. 2017 May 15;523(1):246-259. doi: 10.1016/j.ijpharm.2017.03.029. Epub 2017 Mar 18.

PMID:
28323101
10.

Investigating the effects of size, charge, viscosity and bilayer flexibility on liposomal delivery under convective flow.

Narenji M, Talaee MR, Moghimi HR.

Int J Pharm. 2016 Nov 20;513(1-2):88-96. doi: 10.1016/j.ijpharm.2016.08.056. Epub 2016 Aug 28.

PMID:
27576668
11.

The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.

Ramezani M, Khoshhamdam M, Dehshahri A, Malaekeh-Nikouei B.

Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):1-5. doi: 10.1016/j.colsurfb.2009.03.018. Epub 2009 Apr 2.

PMID:
19395245
12.

Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.

Boakye CH, Patel K, Singh M.

Int J Pharm. 2015 Jul 15;489(1-2):106-16. doi: 10.1016/j.ijpharm.2015.04.059. Epub 2015 Apr 21.

13.

Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.

Maherani B, Arab-Tehrany E, Kheirolomoom A, Geny D, Linder M.

Biochimie. 2013 Nov;95(11):2018-33. doi: 10.1016/j.biochi.2013.07.006. Epub 2013 Jul 16.

PMID:
23871914
14.

Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.

Eskandani M, Nazemiyeh H.

Eur J Pharm Sci. 2014 Aug 1;59:49-57. doi: 10.1016/j.ejps.2014.04.009. Epub 2014 Apr 23.

PMID:
24768857
15.

Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.

Fang G, Tang B, Liu Z, Gou J, Zhang Y, Xu H, Tang X.

Eur J Pharm Sci. 2014 Aug 18;60:1-9. doi: 10.1016/j.ejps.2014.04.016. Epub 2014 May 9.

PMID:
24815943
16.
17.

The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma.

Alavizadeh SH, Badiee A, Golmohammadzadeh S, Jaafari MR.

Int J Pharm. 2014 Oct 1;473(1-2):326-33. doi: 10.1016/j.ijpharm.2014.07.020. Epub 2014 Jul 19.

PMID:
25051111
18.

Nanotherapy for posterior eye diseases.

Kaur IP, Kakkar S.

J Control Release. 2014 Nov 10;193:100-12. doi: 10.1016/j.jconrel.2014.05.031. Epub 2014 May 24. Review.

PMID:
24862316
19.

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

Hathout RM, Mansour S, Mortada ND, Guinedi AS.

AAPS PharmSciTech. 2007 Jan 5;8(1):1.

20.

An efficient dual-loaded multifunctional nanocarrier for combined photothermal and photodynamic therapy based on copper sulfide and chlorin e6.

Tan X, Pang X, Lei M, Ma M, Guo F, Wang J, Yu M, Tan F, Li N.

Int J Pharm. 2016 Apr 30;503(1-2):220-8. doi: 10.1016/j.ijpharm.2016.03.019. Epub 2016 Mar 14.

PMID:
26988376

Supplemental Content

Support Center